part 3 - optimal loco-regional therapy in breast carcinoma after neoadjuvant therapy - dr harit
Published 4 years ago β’ 19 plays β’ Length 16:35Download video MP4
Download video MP3
Similar videos
-
1:09:17
part 3 - session 2 - her2 targeted therapy in breast cancer : integrating newer options
-
23:49
part 2 - debat : neoadjuvant therapy for hr /her 2 negative breast cancer - dr amish vora
-
1:22:30
part 4 - session 3 - triple negative breast cancer : moving ahead
-
6:55
what is neoadjuvant therapy? - breast cancer trials podcast
-
2:54:05
international masterclass in breast cancer 2021 23 oct 2021
-
18:33
part 6 - neo-adjuvant therapy, residual disease, and optimizing adjuvant therapy - dr. b.k.smruti
-
1:23
dr. von minckwitz on non-responsive breast cancer patients
-
10:05
exploring neoadjuvant therapy for breast cancer: what you need to know
-
0:36
discover the difference between adjuvant and neoadjuvant chemotherapy for breast cancer patients ποΈπ¬
-
1:17
comment: phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer pts
-
0:43
understanding the benefits and risks of chemotherapy for breast cancer patients ποΈπ
-
2:03
dr. lori goldstein on neoadjuvant treatment for her2 breast cancer
-
3:28
neoadjuvant treatment strategies for her2-positive breast cancer
-
0:53
what is neoadjuvant therapy?
-
5:38
neoadjuvant therapy with immunotherapy for stage iiib-d melanoma
-
0:55
neoadjuvant chemotherapy how it shapes breast cancer surgery
-
15:35
breast cancer: from diagnosis to loco-regional treatment